The FDA also gave full approval to the Novavax COVID vaccine (Nuvaxovid) using this approach, approving it for those ages 65 and up, along with people ages 12 and up who have at least one underlying condition that puts them at risk of severe disease.

Agency will ask drugmakers for large trials for new versions of vaccines meant for healthy adults and children.

Late-stage trial data suggest that a new COVID-flu vaccine offers good protection against both infections, but experts expect the shot's approval may be delayed.

Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental The U.S. Food and Drug Administration (FDA) has officially approved a COVID-19 vaccine from Novavax for adults 65 and older and for individuals ages 12 to 64 who have an underlying health condition that puts them at higher risk for serious illness from a coronavirus infection.

A vaccine that helps people overcome cocaine addiction has shown signs of being safe and effective in a small trial

Vaccine maker’s £1bn UK investment to create ‘hundreds of high-skilled jobs’ - BioNTech developed mRNA vaccines, and cancer immunotherapies notably used to tackle Covid-19.

Data shows that the two-dose measles vaccine is 97% effective at preventing measles and experts say protection doesn’t wane.